ATA457772A - Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen - Google Patents
Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungenInfo
- Publication number
- ATA457772A ATA457772A AT457772A AT457772A ATA457772A AT A457772 A ATA457772 A AT A457772A AT 457772 A AT457772 A AT 457772A AT 457772 A AT457772 A AT 457772A AT A457772 A ATA457772 A AT A457772A
- Authority
- AT
- Austria
- Prior art keywords
- solid
- manufacturing
- active ingredient
- pharmaceutical preparations
- slow release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1883971A GB1405088A (en) | 1971-06-03 | 1971-06-03 | Slow release formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA457772A true ATA457772A (de) | 1975-04-15 |
AT327390B AT327390B (de) | 1976-01-26 |
Family
ID=10119292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT457772A AT327390B (de) | 1971-06-03 | 1972-05-26 | Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen |
Country Status (18)
Country | Link |
---|---|
US (1) | US4235870A (de) |
JP (1) | JPS569490B1 (de) |
AT (1) | AT327390B (de) |
BE (1) | BE783661A (de) |
CA (1) | CA1009146A (de) |
CH (1) | CH577830A5 (de) |
DE (1) | DE2224534C3 (de) |
DK (1) | DK144306C (de) |
ES (2) | ES403435A1 (de) |
FI (1) | FI55766C (de) |
FR (1) | FR2140217B1 (de) |
GB (1) | GB1405088A (de) |
IL (1) | IL39430A (de) |
NL (1) | NL174619C (de) |
NO (1) | NO138683C (de) |
PH (2) | PH12136A (de) |
SE (1) | SE379636B (de) |
ZA (1) | ZA723207B (de) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1488259A (en) * | 1974-08-28 | 1977-10-12 | Scherer Corp R P | Method for increasing the bioavailability of digitalis cardiac glycosides |
US4002718A (en) * | 1974-10-16 | 1977-01-11 | Arnar-Stone Laboratories, Inc. | Gelatin-encapsulated digoxin solutions and method of preparing the same |
US4076804A (en) * | 1975-07-18 | 1978-02-28 | Abbott Laboratories | Erythromycin therapy |
GB1593261A (en) | 1976-07-23 | 1981-07-15 | Inveresk Res Int | Controlled release suppository |
EP0013131A3 (de) * | 1978-12-27 | 1981-01-07 | Mundipharma A.G. | Pharmazeutische Zusammensetzung in fester Verabreichungsform und Verfahren zu ihrer Herstellung |
IE49324B1 (en) * | 1979-12-19 | 1985-09-18 | Euro Celtique Sa | Controlled release compositions |
US4428925A (en) | 1981-12-18 | 1984-01-31 | Key Pharmaceuticals, Inc. | Sustained release glycerol trinitrate |
US4428926A (en) | 1981-12-18 | 1984-01-31 | Key Pharmaceuticals, Inc. | Sustained release propranolol system |
US4443428A (en) | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
US4432965A (en) * | 1982-07-09 | 1984-02-21 | Key Pharmaceuticals, Inc. | Quinidine sustained release dosage formulation |
GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
NL8500724A (nl) * | 1985-03-13 | 1986-10-01 | Univ Groningen | Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. |
GB8507779D0 (en) * | 1985-03-26 | 1985-05-01 | Fujisawa Pharmaceutical Co | Drug carrier |
GB8514665D0 (en) * | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
GB8521350D0 (en) | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
US4734285A (en) * | 1985-10-28 | 1988-03-29 | The Dow Chemical Company | Sustained release compositions |
US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
GB2186485B (en) * | 1986-02-13 | 1988-09-07 | Ethical Pharma Ltd | Slow release formulation |
US4855143A (en) * | 1986-04-04 | 1989-08-08 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
US4775535A (en) * | 1986-04-04 | 1988-10-04 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
ES2058111T3 (es) * | 1986-06-10 | 1994-11-01 | Euro Celtique Sa | Composicion de liberacion controlada de dihidrocodeina. |
US4861598A (en) * | 1986-07-18 | 1989-08-29 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
US4869908A (en) * | 1987-01-09 | 1989-09-26 | K.V. Pharmaceutical Co. | Fibre formulations |
US5266331A (en) † | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
IL109460A (en) | 1993-05-10 | 1998-03-10 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
US5451409A (en) * | 1993-11-22 | 1995-09-19 | Rencher; William F. | Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |
US5891471A (en) | 1993-11-23 | 1999-04-06 | Euro-Celtique, S.A. | Pharmaceutical multiparticulates |
KR100354702B1 (ko) | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
US5843480A (en) | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
BE1009257A3 (nl) * | 1995-03-21 | 1997-01-07 | Universiteit Gent Lab Voor Far | Farmaceutische matrix. |
US5811126A (en) * | 1995-10-02 | 1998-09-22 | Euro-Celtique, S.A. | Controlled release matrix for pharmaceuticals |
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
DE19918325A1 (de) | 1999-04-22 | 2000-10-26 | Euro Celtique Sa | Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion |
US7052706B2 (en) * | 2001-06-08 | 2006-05-30 | Nostrum Pharmaceuticals, Inc. | Control release formulation containing a hydrophobic material as the sustained release agent |
US20030068375A1 (en) | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
US6780437B2 (en) * | 2001-10-23 | 2004-08-24 | Upsher-Smith Laboratories, Inc. | Coated potassium chloride granules and tablets |
US20050226929A1 (en) * | 2004-04-12 | 2005-10-13 | Jianbo Xie | Controlled release opioid analgesic formulation |
GB0408308D0 (en) | 2004-04-14 | 2004-05-19 | Vectura Ltd | Pharmaceutical compositions |
HUE037643T2 (hu) | 2004-06-12 | 2018-09-28 | Collegium Pharmaceutical Inc | Visszaélésre nem alkalmas gyógyszerkészítmények |
US20080260823A1 (en) * | 2007-04-20 | 2008-10-23 | Sciele Pharma, Inc. | Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
DK2826467T3 (en) | 2010-12-22 | 2017-10-16 | Purdue Pharma Lp | INCLUDED, MANIPULATION-PROPOSED SLOW-DELIVERY DOSAGE FORMS |
CN107412173A (zh) | 2010-12-23 | 2017-12-01 | 普渡制药公司 | 抗篡改固体口服剂型 |
EP3485880A1 (de) | 2012-04-17 | 2019-05-22 | Purdue Pharma LP | Systeme und verfahren zur behandlung einer opioidinduzierten, nachteiligen pharmakodynamischen reaktion |
AU2014215478B2 (en) | 2013-02-05 | 2018-09-13 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
US9849124B2 (en) | 2014-10-17 | 2017-12-26 | Purdue Pharma L.P. | Systems and methods for treating an opioid-induced adverse pharmacodynamic response |
US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2921883A (en) * | 1957-05-03 | 1960-01-19 | Smith Kline French Lab | Novel coating material for medicaments |
US3079303A (en) * | 1958-12-11 | 1963-02-26 | Smith Kline French Lab | Basic tablet granulation and process of using same |
US3065143A (en) * | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
US3108046A (en) * | 1960-11-25 | 1963-10-22 | Smith Kline French Lab | Method of preparing high dosage sustained release tablet and product of this method |
US3133863A (en) * | 1961-03-10 | 1964-05-19 | Strong Cobb Arner Inc | Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums |
US3146167A (en) * | 1961-10-05 | 1964-08-25 | Smith Kline French Lab | Method of preparing sustained release pellets and products thereof |
DE1185336B (de) * | 1961-12-14 | 1965-01-14 | American Cyanamid Co | Verfahren zur Herstellung von pharmazeutischen Praeparaten |
NL113512C (de) * | 1962-01-25 | |||
US3147187A (en) * | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
-
1971
- 1971-06-03 GB GB1883971A patent/GB1405088A/en not_active Expired
-
1972
- 1972-05-10 ZA ZA723207A patent/ZA723207B/xx unknown
- 1972-05-12 IL IL39430A patent/IL39430A/xx unknown
- 1972-05-18 BE BE783661A patent/BE783661A/xx not_active IP Right Cessation
- 1972-05-19 DE DE2224534A patent/DE2224534C3/de not_active Expired
- 1972-05-23 FI FI1442/72A patent/FI55766C/fi active
- 1972-05-24 CA CA142,880A patent/CA1009146A/en not_active Expired
- 1972-05-26 AT AT457772A patent/AT327390B/de not_active IP Right Cessation
- 1972-05-31 CH CH804672A patent/CH577830A5/xx not_active IP Right Cessation
- 1972-06-01 PH PH13593A patent/PH12136A/en unknown
- 1972-06-02 NO NO1969/72A patent/NO138683C/no unknown
- 1972-06-02 JP JP5554372A patent/JPS569490B1/ja active Pending
- 1972-06-02 NL NLAANVRAGE7207486,A patent/NL174619C/xx not_active IP Right Cessation
- 1972-06-02 FR FR7219993A patent/FR2140217B1/fr not_active Expired
- 1972-06-02 DK DK277372A patent/DK144306C/da not_active IP Right Cessation
- 1972-06-02 SE SE7207280A patent/SE379636B/xx unknown
- 1972-06-02 ES ES403435A patent/ES403435A1/es not_active Expired
-
1974
- 1974-03-22 ES ES424533A patent/ES424533A1/es not_active Expired
-
1975
- 1975-12-15 US US05/641,069 patent/US4235870A/en not_active Expired - Lifetime
-
1976
- 1976-04-07 PH PH18304A patent/PH14809A/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2140217B1 (de) | 1976-03-12 |
DE2224534B2 (de) | 1977-10-20 |
DE2224534C3 (de) | 1981-04-02 |
AT327390B (de) | 1976-01-26 |
US4235870A (en) | 1980-11-25 |
FR2140217A1 (de) | 1973-01-12 |
NO138683B (no) | 1978-07-17 |
NL174619B (nl) | 1984-02-16 |
GB1405088A (en) | 1975-09-03 |
PH12136A (en) | 1978-11-07 |
DK144306C (da) | 1982-07-12 |
CA1009146A (en) | 1977-04-26 |
CH577830A5 (de) | 1976-07-30 |
BE783661A (fr) | 1972-09-18 |
DE2224534A1 (de) | 1972-12-14 |
PH14809A (en) | 1981-12-14 |
ZA723207B (en) | 1973-03-28 |
NL7207486A (de) | 1972-12-05 |
FI55766B (fi) | 1979-06-29 |
IL39430A (en) | 1975-12-31 |
ES424533A1 (es) | 1977-02-16 |
JPS569490B1 (de) | 1981-03-02 |
FI55766C (fi) | 1979-10-10 |
NO138683C (no) | 1978-10-25 |
NL174619C (nl) | 1984-07-16 |
ES403435A1 (es) | 1975-05-01 |
SE379636B (de) | 1975-10-20 |
DK144306B (da) | 1982-02-15 |
IL39430A0 (en) | 1972-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT327390B (de) | Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen | |
AT299195B (de) | Verfahren zur Herstellung von N-(1,1,1,-trisubstituierten)-Methylazolen | |
CH473089A (de) | Verfahren zur Herstellung von neuen pharmazeutischen Amino-Verbindungen | |
AT303040B (de) | Verfahren zur Herstellung von neuen Azidophenyl-1,4-dihydroppyridinen | |
AT319948B (de) | Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen | |
AT310184B (de) | Verfahren zur Herstellung von neuen 1,3,4-Thiadiazolyl-(5)-harnstoffen | |
AT312606B (de) | Verfahren zur Herstellung von neuen 2,2-Diaryl-4-piperidinbutyramiden | |
AT306228B (de) | Verfahren zur Herstellung pharmazeutischer Zubereitungen | |
AT299968B (de) | Verfahren zur Herstellung von neuen 5-Imino-1,2,4-triazin-Derivaten | |
AT307802B (de) | Verfahren zur Herstellung von gebrauchsfertigen, pestiziden Zubereitungen | |
AT327373B (de) | Verfahren zur herstellung pharmazeutischer zubereitungen | |
CH534662A (de) | Verfahren zur Herstellung von alkylierten N,N'-Diphenyloxamiden | |
AT266324B (de) | Verfahren zur Herstellung von festen pharmazeutischen Präparaten zur stufenweisen Abgabe von Wirkstoffen | |
CH546730A (de) | Verfahren zur herstellung von n,n'-bis-trifluormethyl-tetrafluoraethylendiamin. | |
AT319269B (de) | Verfahren zur Herstellung von O,O-Dialky-O-(2,2-dichlorvinyl)-thionophosphorsäureestern | |
AT309393B (de) | Verfahren zur Herstellung von reinem 2,2-Dimethylpropandiol-(1,3) | |
AT314542B (de) | Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen | |
AT306259B (de) | Verfahren zur Herstellung von neuen 3-Oxo-11β,18-epoxy-17α-R-17β-hydroxyöstra-4,9-dienen | |
NL169735C (nl) | Werkwijze ter bereiding of vervaardiging van anti-inflammatoir werkzame farmaceutische preparaten; alsmede werkwijze ter bereiding van anti-inflammatoir werkzame, op plaats 4 met een via stikstof gebonden, stikstof bevattende heterocyclische rest gesubstitueerde alfa-fenylpropionzuurderivaten. | |
CH540276A (de) | Verfahren zur Herstellung von neuen, virustatisch wirksamen 4,5-Diphenyl-oxazolyl-(2)-hydrazonen | |
AT327874B (de) | Verfahren zur herstellung von 5-hydroxy- oder 5-acetoxy-4,4-diphenyl-2-aminoheptan und deren pharmazeutisch verwendbaren saureadditionssalzen | |
AT340581B (de) | Verfahren zur herstellung von pharmazeutischen praparaten mit synergistischer, analgetischer wirkung | |
NL179205C (nl) | Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte aminoalkylesters van xantheen-9-carbonzuur. | |
CH467263A (de) | Verfahren zur Herstellung pharmakologisch wirksamer 9,9-Dialkylacridan-10-propion-säureester | |
AT303067B (de) | Verfahren zur Herstellung von neuen O,O-Dialkyl-S-phenyl-dithiophosphorsäureestern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELA | Expired due to lapse of time |